New Asthma Research Findings: CARE Study

New evidence for Anti-inflammatory Reliever Therapy (AIR) in children aged 5-15 with mild asthma. The New Zealand CARE study confirmed that inhaled Budesonide (an anti-inflammatory controller) in combination with formoterol (a fast acting, long-acting bronchodilator ) is more effective than salbutamol reliever in reducing asthma attacks. T the combination Anti-inflammatory reliever inhaler instead of a salbutamol reliever for relief of symptoms led to a reduction of asthma attacks in about half of those studied.There is now no rationale for prescribing salbutamol alone for relief of symptoms without an inhaled corticosteroid in children 5 years and over who have asthma. For more information see https://bit.ly/4nPGRzc and www.ginasthma.orgAsthma Spotlight PODCAST Disclaimer: The opinions I express in this Asthma Spotlight PODCAST are not intended as, and shall not be understood or construed as, medical, health, or professional advice of any kind. The information contained in this podcast is an educational service that provides general health information about asthma and is not a substitute for medical or health advice from a professional who is aware of the facts and circumstances of your individual situation. This podcast contains my own opinions. I will make every effort to broadcast correct information but listeners must realize that medicine is a constantly changing science and art. One doctor may have a different way of doing things from another. I am simply presenting my views on asthma that will be as evidence based as possible I do not promote any asthma medications or devices. By listening to this podcast, which is intended for people with asthma and their caregivers, you agree not to use this podcast or blog as medical advice to treat any medical condition in either yourself or others, and if you are a health professional, this  includesbut is not limited to patients that you are treating.  Consult your own physician for any medical issues that you may be having. This entire disclaimer also applies to any guests or contributors to the podcast or blog. You understand and agree that under no circumstances shall Dr Mark Levy any guests or contributors to the podcast or blog be responsible for damages arising from use of the podcast or blog.ADDITIONAL LEGAL DISCLAIMER All Asthma Spotlight Podcast: This blog or podcast should not be used in any legal capacity whatsoever, including but not limited to establishing “standard of care” in a legal sense or as a basis for expert witness testimony. No guarantee is given regarding the accuracy of any statements or opinions made on the podcast or blog.Privacy notice Asthma Spotlight Podcast:  While you may give your email address to me if you send any questions to [email protected] to be answered in future podcasts, I will never share your email address or contact information with any third parties without your explicit permission.Advertising policy Asthma Spotlight Podcast:   The Asthma Spotlight podcast may receive advertising money; Dr Mark Levy and any other presenters on Asthma Spotlight podcast do NOT endorse any of the adverts placed on the site. Hosted on Acast. See acast.com/privacy for more information.